Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- indium oxyquinoline in-111
- ofloxacin
Interactions between your drugs
ofloxacin indium oxyquinoline In-111
Applies to: ofloxacin, indium oxyquinoline in-111
Treatment with ofloxacin can interfere with indium oxyquinoline In-111 test results. Let your doctor know you are on ofloxacin if you are scheduled for a indium oxyquinoline In-111 test. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food/lifestyle interactions
ofloxacin food/lifestyle
Applies to: ofloxacin
Consumer information for this interaction is not currently available.
GENERALLY AVOID: The oral bioavailability of quinolone and tetracycline antibiotics may be reduced by concurrent administration of preparations containing polyvalent cations such as aluminum, calcium, iron, magnesium, and zinc. Therapeutic failure may result. The proposed mechanism is chelation of quinolone and tetracycline antibiotics by di- and trivalent cations, forming an insoluble complex that is poorly absorbed from the gastrointestinal tract. Reduced gastrointestinal absorption of the cations should also be considered.
MANAGEMENT: Concomitant administration of oral quinolone and tetracycline antibiotics with preparations containing aluminum, calcium, iron, magnesium, and/or zinc salts should generally be avoided. Otherwise, the times of administration should be staggered by as much as possible to minimize the potential for interaction. Quinolones should typically be dosed either 2 to 4 hours before or 4 to 6 hours after polyvalent cation preparations, depending on the quinolone and formulation. Likewise, tetracyclines and polyvalent cation preparations should typically be administered 2 to 4 hours apart. The prescribing information for the antibiotic should be consulted for more specific dosing recommendations.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
AdreView
AdreView is a molecular imaging agent used to help diagnose adrenal gland tumors. Learn about side ...
Amyvid
Amyvid (florbetapir F 18) is used to detect plaque in the brain of patients who are being evaluated ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Axumin
Axumin is used for diagnosis and investigation, positron emission tomography imaging
Cardiogen-82
Cardiogen-82 is used for positron emission tomography imaging
Cerianna
Cerianna is used for diagnosis and investigation, positron emission tomography imaging
DaTscan
DaTscan (ioflupane I 123) is used to detect Parkinson's disease in people with symptoms such as ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.